Published May 1, 2021, 5:00 PM
A “huge gap” between demand and supply of vaccines is threatening the rebound across developing Asia, according to Asian Development Bank President Masatsugu Asakawa.
“We need to invest more in vaccine manufacturing companies in the region to expand the production function,” Asakawa said in the Bloomberg Television interview with Haslinda Amin.
Masatsugu Asakawa, ADB president (Photo credit: https://www.adb.org)
The ADB has made progress in providing financing to help the vaccine production, Asakawa said. A $9 billion financing instrument approved in December the Asia Pacific Vaccine Access Facility, or APVAX has approved four constituencies for funding: Indonesia, Philippines, Afghanistan and South Pacific islands.
BusinessWorld
April 30, 2021 | 6:41 pm
Coronavirus vaccine roll-outs have been delayed throughout Southeast Asia, including the Philippines. Photo by Michael Varcas, The Philippine Star
A âhuge gapâ between demand and supply of vaccines is threatening the rebound across developing Asia, according to Asian Development Bank President Masatsugu Asakawa.
âWe need to invest more in vaccine manufacturing companies in the region to expand the production function,â Asakawa said in the Bloomberg Television interview with Haslinda Amin.
The ADB has made progress in providing financing to help the vaccine production, Asakawa said. A $9 billion financing instrument approved in December the Asia Pacific Vaccine Access Facility, or APVAX has approved four constituencies for funding: Indonesia, Philippines, Afghanistan and South Pacific islands.
ADB Approves $18.9 Million for Rollout of COVID-19 Vaccines in the Pacific
News Release | 26 April 2021
MANILA, PHILIPPINES (26 April 2021) The Asian Development Bank (ADB) has approved $18.9 million in grants to help four developing member countries (DMCs) in the Pacific roll out safe and effective vaccines against the coronavirus disease (COVID-19).
The grants to Samoa ($8 million), Tonga ($5.5 million), Tuvalu ($1.5 million), and Vanuatu ($3.9 million) will support their COVID-19 vaccination programs for a combined population of almost 600,000 people. The project is financed by ADB’s $9 billion Asia Pacific Vaccine Access Facility launched in December 2020 to offer rapid and equitable vaccine-related support to ADB’s DMCs.
ADB Approves USD$18.9 Million for Rollout of COVID-19 Vaccines in the Pacific
As of March 2021, ADB had committed more than USD$750 million, including in cofinancing and technical assistance, to support Pacific countries respond to the pandemic.
Source: PAHO Monday, 26 April 2021 13:34 PM
The Asian Development Bank (ADB) has approved $18.9 million in grants to help four developing member countries (DMCs) in the Pacific roll out safe and effective vaccines against the coronavirus disease (COVID-19).
The grants to Samoa ($8 million), Tonga ($5.5 million), Tuvalu ($1.5 million), and Vanuatu ($3.9 million) will support their COVID-19 vaccination programs for a combined population of almost 600,000 people. The project is financed by ADB’s $9 billion Asia Pacific Vaccine Access Facility launched in December 2020 to offer rapid and equitable vaccine-related support to ADB’s DMCs.